Locally advanced bladder urothelial carcinoma
Clinical trials for Locally advanced bladder urothelial carcinoma explained in plain language.
Never miss a new study
Get alerted when new Locally advanced bladder urothelial carcinoma trials appear
Sign up with your email to follow new studies for Locally advanced bladder urothelial carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail of drugs takes on Hard-to-Treat bladder cancer
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs—enfortumab vedotin, pembrolizumab, and quemliclustat—in people with advanced bladder or urinary tract cancer that has spread or cannot be removed by surgery. The goal is to see if the combination is safe and effective. The…
Matched conditions: LOCALLY ADVANCED BLADDER UROTHELIAL CARCINOMA
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising drug duo before bladder removal shows hope for advanced cancer patients
Disease control Recruiting nowThis study tests whether giving a targeted drug (enfortumab vedotin) plus an immunotherapy (pembrolizumab) before surgery to remove part or all of the bladder can improve outcomes for people with advanced bladder or urinary tract cancer. About 75 adults with cancer that has sprea…
Matched conditions: LOCALLY ADVANCED BLADDER UROTHELIAL CARCINOMA
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC